Product Offerings
Product Categories:
Organoids, Drug Evaluation, AI Analysis
Products:
Patient-Derived Organoids (PDO), Organoid Culture, Drug Evaluation Platforms, AI-Based Analysis Algorithms
Product Gallery:
Loading...
Organoids, Drug Evaluation, AI Analysis
Patient-Derived Organoids (PDO), Organoid Culture, Drug Evaluation Platforms, AI-Based Analysis Algorithms
Gradiant Bioconvergence specializes in the development and application of organoid culture technology, providing comprehensive contract research services. The company focuses on patient-derived organoid (PDO) banking, drug evaluation platforms, and AI-based analysis algorithms to support innovative drug discovery and development.